ARADHANA SARIN Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ARADHANA SARIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARADHANA SARIN. ARADHANA SARIN is Chief Strategy & Business Off in ALEXION PHARMACEUTICALS, INC. ($ALXN) and EVP, CFO in ALEXION PHARMACEUTICALS, INC. ($ALXN) and Director in ORASURE TECHNOLOGIES INC ($OSUR).
ARADHANA SARIN in ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ARADHANA SARIN: EVP, CFO, Chief Strategy & Business Off
Holdings: 63,940 shares
Current Value: $8,166,417
Latest Transaction: Mar 02 2021
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ARADHANA SARIN in ALEXION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Grant | A | 0.00 | 24,473 | 0 | 63,940 | 39.5 K to 63.9 K (+62.01 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 157.96 | 2,510 | 396,480 | 39,467 | 42 K to 39.5 K (-5.98 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 157.96 | 6,853 | 1,082,500 | 41,977 | 48.8 K to 42 K (-14.03 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Grant | A | 0.00 | 15,371 | 0 | 48,830 | 33.5 K to 48.8 K (+45.94 %) |
| Dec 01 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 124.00 | 1,298 | 160,952 | 33,459 | 34.8 K to 33.5 K (-3.73 %) |
| Dec 04 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 113.20 | 5,441 | 615,921 | 24,760 | 30.2 K to 24.8 K (-18.02 %) |
| Jun 24 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Sell | S | 132.00 | 578 | 76,296 | 30,201 | 30.8 K to 30.2 K (-1.88 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Grant | A | 0.00 | 8,250 | 0 | 30,779 | 22.5 K to 30.8 K (+36.62 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Payment of Exercise | F | 132.92 | 267 | 35,490 | 22,529 | 22.8 K to 22.5 K (-1.17 %) |
Page: 1